logo

OCTOBER 29-NOVEMBER 2, 2017
COLORADO CONVENTION CENTER
DENVER, COLORADO

Press Room and Press Briefing Policy

Only members of the media with a credentialed press badge will have access to the Press Room during hours of operation.

Executives, researchers, investigators, and industry leaders who are participating in press briefings, scheduled press events, and media interviews will have access to the Press Conference Room during these activities. These individuals may be accompanied by their public relations representatives (a maximum of three individuals in total) during these activities.

Public relations and industry representatives will not have access to the Press Room and are prohibited from soliciting media in or around the Press Room. They may, however, call upon the Press Room staff to help them facilitate media requests. Company or product literature, statements, or news releases may not be distributed in the adjacent hallways and areas around the Press Conference Room and Press Room.

Only pre-approved media materials may be made available in the press area. Press releases must mention Transcatheter Cardiovascular Therapeutics (TCT) and the Cardiovascular Research Foundation (CRF) in order to have them placed in the press area (see News Release Policy.)

Hosting Media Events during TCT 2017

Exhibiting companies are permitted to hold on-site media events at Walter E. Washington Convention Center during TCT provided that they relate directly to research presented at TCT 2016 and do not conflict with official TCT 2017 press activities or policies.

Companies planning on-site media events are required to obtain written approval from CRF in advance of the meeting by contacting CRF’s Director of External Relations, Irma Damhuis at idamhuis@crf.org. Additionally, companies must coordinate timing and location with the CRF Press Office, which will facilitate requests for convention center space during the conference. Space will be available on a first-come, first-served basis.

Exhibiting companies are asked to hold their off-site press events or analyst briefings during dates and times that do not conflict with official TCT 2017 press activities. CRF will conduct press conferences on Monday, October 30; Tuesday, October 31; Wednesday, November 1; and Thursday, November 2 between 7:00 AM and 3:00 PM MT. A final schedule of media events will be available from the CRF Press Office a few weeks in advance of TCT 2017.

Embargo Policy

Late-Breaking Clinical Trials/First Report Investigations

The Cardiovascular Research Foundation embargoes information presented as a late-breaking clinical trial or first report investigation from becoming public until after the start time of each trial’s Main Arena presentation as listed in the TCT 2017 Program or on the official TCT website. No exhibitor or university (or affiliated organization or company) may disseminate information until after the trial’s official Main Arena presentation time has passed. All embargo times are listed in Mountain Time (MT).

Abstracts

Coverage of all other abstracts being presented at TCT is strictly prohibited until the start of the meeting on Sunday, October 29, 2017.

Violation of TCT embargo policies can result in removal of the research from the scientific program, removal of individuals and/or companies from the meeting, and revocation of media credentials. It is the exhibitor’s responsibility to know whether its data is subject to the embargo regulation.

For questions regarding the embargo policy, please email press@crf.org.

News Release Policy

Industry may display news releases in the press area provided they adhere to the following policy:

  • Only companies exhibiting or presenting research at TCT 2016 may display materials in the press area. All press materials must relate directly to the meeting. CRF reserves the right to prohibit and/or discard materials deemed scientifically misleading, ethically questionable, or irrelevant to the meeting.
  • All news releases must abide by CRF’s embargo policy and will not be permitted to be displayed or released in the press area prior to the embargo date and time.
  • Releases must reference the Cardiovascular Research Foundation’s annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in the body of the release, preferably in the first paragraph. Suggested language is provided below.
  • A copy of the press release, or draft press release, must be submitted in advance for review and approval. For advance approval on press releases, please email the press release to the contact below. News releases will be held in the strictest confidence.

CRF Press Office Contact:
Judy Romero
P: 646-434-4608
jromero@crf.org

Suggested Language (Included in first paragraph)

…….presented at the 28th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation.

Language for CRF and TCT (Optional use)

The Cardiovascular Research Foundation (CRF) is a nonprofit research and educational organization dedicated to helping doctors improve survival and quality of life for people suffering from heart and vascular disease. For over 25 years, CRF has helped pioneer innovations in interventional cardiology and has educated doctors on the latest treatments for heart disease.

Transcatheter Cardiovascular Therapeutics (TCT) is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine. Now in its 29th year, TCT features major medical research breakthroughs and gathers leading researchers and clinicians from around the world to present and discuss the latest evidence-based research in the field.

For more information, visit www.crf.org and www.tctconference.com.

Media Attendance/Media List

The TCT scientific symposium routinely attracts more than 100 medical and business reporters from a wide range of disciplines, including national wire services, newspapers, U.S. and international trade publications (cardio/pharma/medical/device), and popular news and health-information websites.

The Cardiovascular Research Foundation does not provide a media or attendee registration list of any type.

Social Media

Communicating about TCT research and educational content through social media is encouraged within embargo restrictions. The Twitter hashtag for this year’s meeting is #TCTDenver. Follow @CRFheart and @TCTConference for meeting updates.

Photographing, Videotaping, and Audio Recording

Photographing, videotaping, and/or audio recording including the use of cell phone cameras is permissible only in an exhibiting company’s own booth. Please see Exhibitor Rules and Regulations for more information.

 

These policies were last updated January 26, 2017, and are subject to change. Please check with the CRF Press Office for further updates.